AMRI NASDAQ
Albany Molecular Research, Inc.
1W: +0.1%
1M: +0.1%
3M: +7.8%
1Y: +46.7%
3Y: +12.6%
5Y: +550.9%
$21.74
Last traded 2017-08-31 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$27M
-32.8% ▼
Capital Expenditures
$51M
-133.3% ▼
5Y CAGR: +36.5%
Free Cash Flow
-$25M
-241.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$974K
-18.2% ▼
Net Change in Cash
$3M
+13.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | $13M | -$3M | -$2M | -$70M |
| Depreciation & Amort. | $17M | $15M | $14M | $30M | $57M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $15M | $158M | -$93M | $39M | $36M |
| Other Non-Cash Items | -$18M | -$160M | $78M | -$36M | -$4M |
| Operating Cash Flow | $15M | $28M | $2M | $40M | $27M |
| — Investing Activities — | |||||
| Capital Expenditures | $8M | -$11M | -$17M | -$22M | -$51M |
| Acquisitions (Net) | $0 | $0 | -$146M | -$200M | -$142M |
| Investment Purchases | $0 | -$164K | -$579K | -$824K | -$974K |
| Investment Sales | $213K | $0 | $0 | $0 | $0 |
| Other Investing | -$18M | $53K | $261K | -$251K | -$405K |
| Investing Cash Flow | -$10M | -$11M | -$163M | -$223M | -$195M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | -$164K | -$579K | -$824K | -$974K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$3M | $137M | $33M | $185M | $171M |
| Financing Cash Flow | -$3M | $137M | $33M | $185M | $171M |
| Net Change in Cash | $3M | $153M | -$129M | $2M | $3M |
| Cash End of Period | $23M | $176M | $47M | $49M | $52M |
| Free Cash Flow | $24M | $17M | -$15M | $18M | -$25M |